Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in japanese type 2 diabetic patients
- PMID: 15331559
- DOI: 10.2337/diabetes.53.9.2455
Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in japanese type 2 diabetic patients
Abstract
Atherosclerosis in type 2 diabetic patients has been linked to increased oxidative stress. Glutathione peroxidase-1 (GPx-1) plays an important role in the antioxidant defense of the vascular wall. To assess the association between variants in the GPx-1 gene and atherosclerosis, we screened the gene in 184 Japanese type 2 diabetic patients and identified four polymorphisms (-602A/G, +2C/T, Ala(5)/Ala(6), and Pro198Leu). Among these polymorphisms, -602G, +2T, Ala(6), and 198Leu were in strong linkage disequilibrium with each other. The patients were divided into two groups on the basis of the codon 198 polymorphism, Pro/Pro (n = 151) and Pro/Leu (n = 33), to analyze clinical characteristics. The mean intima-media thickness (IMT) of common carotid arteries (P = 0.0028) and the prevalence of cardiovascular disease (P = 0.035) and peripheral vascular disease (P = 0.027) were significantly higher in the Pro/Leu group than in the Pro/Pro group. In vitro functional analyses indicated that the combination of polymorphisms (Ala(6)/198Leu) of the GPx-1 gene had a 40% decrease in enzyme activity, and the combination of polymorphisms (-602G/+2T) had a 25% decrease in transcriptional activity. These results suggest that functional variants in the GPx-1 gene are associated with increased IMT of carotid arteries and risk of cardiovascular and peripheral vascular diseases in type 2 diabetic patients.
Similar articles
-
Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans.Circ Res. 2010 Apr 16;106(7):1303-11. doi: 10.1161/CIRCRESAHA.109.210294. Epub 2010 Feb 25. Circ Res. 2010. PMID: 20185798 Free PMC article.
-
Cerebrovascular disease in diabetes mellitus: the role of carotid intima-media thickness.Nutr Metab Cardiovasc Dis. 2009 Nov;19(9):667-73. doi: 10.1016/j.numecd.2009.03.014. Epub 2009 Jun 5. Nutr Metab Cardiovasc Dis. 2009. PMID: 19500958 Review.
-
Association of plasma PAF acetylhydrolase gene polymorphism with IMT of carotid arteries in Japanese type 2 diabetic patients.Diabetes Res Clin Pract. 2003 Mar;59(3):219-24. doi: 10.1016/s0168-8227(02)00245-0. Diabetes Res Clin Pract. 2003. PMID: 12590019
-
Coronary artery disease and carotid artery intima-media thickness in Japanese type 2 diabetic patients.Diabetes Care. 2002 Aug;25(8):1308-12. doi: 10.2337/diacare.25.8.1308. Diabetes Care. 2002. PMID: 12145226
-
Carotid intima-media thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus.Wien Klin Wochenschr. 2000 Oct 27;112(20):887-91. Wien Klin Wochenschr. 2000. PMID: 11244615
Cited by
-
Assessing the possible association between MTHFR (rs1801133) and GPx-1 (rs1050450) polymorphisms with the risk of type 2 diabetes, diabetic neuropathy, and diabetic retinopathy.Mol Biol Rep. 2024 Apr 29;51(1):583. doi: 10.1007/s11033-024-09519-0. Mol Biol Rep. 2024. PMID: 38683407
-
NADPH Oxidase 3: Beyond the Inner Ear.Antioxidants (Basel). 2024 Feb 8;13(2):219. doi: 10.3390/antiox13020219. Antioxidants (Basel). 2024. PMID: 38397817 Free PMC article. Review.
-
Current Understanding of Human Polymorphism in Selenoprotein Genes: A Review of Its Significance as a Risk Biomarker.Int J Mol Sci. 2024 Jan 24;25(3):1402. doi: 10.3390/ijms25031402. Int J Mol Sci. 2024. PMID: 38338681 Free PMC article. Review.
-
Variability of DNA Repair and Oxidative Stress Genes Associated with Worst Pain in Breast Cancer Survivors on Aromatase Inhibitors.Genes (Basel). 2023 Oct 31;14(11):2031. doi: 10.3390/genes14112031. Genes (Basel). 2023. PMID: 38002974 Free PMC article.
-
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies.Signal Transduct Target Ther. 2023 May 27;8(1):220. doi: 10.1038/s41392-023-01439-y. Signal Transduct Target Ther. 2023. PMID: 37244925 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous